Chloroquine embryotoxicity in the postimplantation rat conceptus in vitro.

The embryotoxicity of the antimalarial drug chloroquine (CQ) was evaluated in vitro using the rat whole embryo culture system. CQ was found to be embryotoxic and dysmorphogenic when added directly to the culture media containing gestational day (GD) 10 rat conceptuses. Twenty-six-hr exposure to CQ elicited dose-related decreases in embryonic crown-rump length, protein and DNA contents and increases in the incidence of morphologically abnormal embryos. At 30 microM CQ, embryonic protein content was decreased to 67% and DNA content to 58% of control while the incidence of morphological abnormalities rose to 100%. Abnormal axial rotation, micro-ophthalmia, and selective cephalic hypoplasia were the most common developmental abnormalities observed. Visceral yolk sac (VYS) vasculature and blood pigmentation were also decreased in a dose-dependent manner, as was VYS DNA content (80% of control at 30 microM). VYS protein content, however, showed an alternate pattern of response, decreasing to 87% of control at 10 microM CQ but increasing to 125% of control at 30 microM. Histologic evaluation revealed that the cytoplasm of the VYS endoderm epithelium was distended due to vacuolization produced by CQ exposure. In the embryo proper, CQ inhibited cranial neural tube development and altered the morphology of cranial neural crest cells. These observations document the in vitro embryotoxicity of CQ and suggest altered VYS histiotrophic nutrition as well as direct embryonic effects as possible mechanisms of CQ embryotoxicity.

[1]  P. McGuire,et al.  Transforming growth factor-beta alters differentiation in cultures of avian neural crest-derived cells: effects on cell morphology, proliferation, fibronectin expression, and melanogenesis. , 1992, Developmental biology.

[2]  M. Bronner‐Fraser,et al.  Collagens in avian neural crest development: distribution in vivo and migration-promoting ability in vitro. , 1991, Development.

[3]  D. Gladman,et al.  Pregnancy Outcome Following First Trimester Exposure to Chloroquine , 1991, American journal of perinatology.

[4]  E. S. Hunter,et al.  Altered visceral yolk sac function produced by a low-molecular-weight somatomedin inhibitor. , 1991, Teratology.

[5]  G. Daston,et al.  Effects of lysosomal proteinase inhibition on the development of the rat embryo in vitro. , 1991, Teratology.

[6]  C. Harris,et al.  Morphological differences elicited by two weak acids, retinoic and valproic, in rat embryos grown in vitro. , 1991, Teratology.

[7]  R. Brent,et al.  Experimental manipulation of the rodent visceral yolk sac. , 1990, Teratology.

[8]  R. Brent,et al.  Experimental yolk sac dysfunction as a model for studying nutritional disturbances in the embryo during early organogenesis. , 1990, Teratology.

[9]  J. Lloyd Cell physiology of the rat visceral yolk sac: a study of pinocytosis and lysosome function. , 1990, Teratology.

[10]  Archana Sharma,et al.  Toxicological consequences of chloroquine and ethanol on the developing fetus , 1989, Pharmacology Biochemistry and Behavior.

[11]  A. Shimizu,et al.  Kinetic study of internalization and degradation of 131I-labeled follicle-stimulating hormone in mouse Sertoli cells and its relevance to other systems. , 1989, The Journal of biological chemistry.

[12]  C. Harris,et al.  Modulation of the embryotoxicity and cytotoxicity elicited by 7-hydroxy-2-acetylaminofluorene and acetaminophen via deacetylation. , 1989, Toxicology and applied pharmacology.

[13]  J. Duband,et al.  Cell-adhesion and substrate-adhesion molecules: their instructive roles in neural crest cell migration. , 1988, Development.

[14]  D. Noden Interactions and fates of avian craniofacial mesenchyme. , 1988, Development.

[15]  C. Harris,et al.  Embryotoxicity elicited by inhibition of gamma-glutamyltransferase by Acivicin and transferase antibodies in cultured rat embryos. , 1987, Toxicology and applied pharmacology.

[16]  G. Morriss-Kay,et al.  Analysis of cranial neural crest cell migration and early fates in postimplantation rat chimaeras. , 1986, Journal of embryology and experimental morphology.

[17]  P. Schlesinger,et al.  A perspective on antimalarial action: effects of weak bases on Plasmodium falciparum. , 1986, Biochemical pharmacology.

[18]  E. Cerasi,et al.  Binding, degradation, and biological activity of insulin in vascular smooth muscle cells. , 1985, The American journal of physiology.

[19]  M. Wolfe,et al.  Safety of chloroquine in chemosuppression of malaria during pregnancy. , 1985, British medical journal.

[20]  N. White,et al.  In Vivo Chloroquine-induced Inhibition of Insulin Degradation in a Diabetic Patient with Severe Insulin Resistance , 1984, Diabetes.

[21]  J. Lloyd,et al.  Inhibition of proteolysis in rat yolk sac as a cause of teratogenesis. Effects of leupeptin in vitro and in vivo. , 1983, Journal of embryology and experimental morphology.

[22]  A. Mackenzie,et al.  Pharmacologic actions of 4-aminoquinoline compounds. , 1983, The American journal of medicine.

[23]  W. Sly,et al.  The role of intermediate vesicles in the adsorptive endocytosis and transport of ligand to lysosomes by human fibroblasts , 1983, The Journal of cell biology.

[24]  J. Lloyd,et al.  Evidence that protein ingested by the rat visceral yolk sac yields amino acids for synthesis of embryonic protein. , 1983, Journal of embryology and experimental morphology.

[25]  F. Nato,et al.  Approach to the mechanism of Zajdela's hepatoma cell growth inhibition induced by concanavalin A and phytohaemagglutinin. , 1982, Biochimica et biophysica acta.

[26]  B. Posner,et al.  Effect of chloroquine on the internalization of 125I-insulin into subcellular fractions of rat liver. Evidence for an effect of chloroquine on Golgi elements. , 1982, The Journal of biological chemistry.

[27]  E. Essien,et al.  Chloroquine and its metabolites in human cord blood, neonatal blood, and urine after maternal medication. , 1982, Clinical chemistry.

[28]  R. Crichton,et al.  Transferrin uptake by cultured rat embryo fibroblasts. The influence of lysosomotropic agents, iron chelators and colchicine on the uptake of iron and transferrin. , 1982, European journal of biochemistry.

[29]  J. Lloyd,et al.  The role of the visceral yolk sac in mediating protein utilization by rat embryos cultured in vitro. , 1981, Journal of embryology and experimental morphology.

[30]  Richard G. W. Anderson,et al.  Monensin interrupts the recycling of low density lipoprotein receptors in human fibroblasts , 1981, Cell.

[31]  G. Livesey,et al.  Effects of weak bases on the degradation of endogenous and exogenous proteins by rat yolk sacs. , 1980, The Biochemical journal.

[32]  J. Grubb,et al.  Chloroquine inhibits lysosomal enzyme pinocytosis and enhances lysosomal enzyme secretion by impairing receptor recycling , 1980, The Journal of cell biology.

[33]  A. C. King,et al.  Lysomotropic amines cause intracellular accumulation of receptors for epidermal growth factor. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[34]  P. Schlesinger,et al.  Chloroquine and ammonium ion inhibit receptor-mediated endocytosis of mannose-glycoconjugates by macrophages: apparent inhibition of receptor recycling. , 1980, Biochemical and biophysical research communications.

[35]  K. Paigen,et al.  A simple, rapid, and sensitive DNA assay procedure. , 1980, Analytical biochemistry.

[36]  P. Libby,et al.  Degradation of the acetylcholine receptor in cultured muscle cells: Selective inhibitors and the fate of undegraded receptors , 1980, Cell.

[37]  B Poole,et al.  Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[38]  W. Landauer Cholinomimetic teratogens. VI. The interaction of cholinomimetic teratogens with the antimalarial drugs chloroquine and chlorguanide. , 1978, Teratology.

[39]  M. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[40]  K. L. Yielding,et al.  Preliminary study of caffeine and chloroquine enhancement of x-ray induced birth defects. , 1976, Biochemical and biophysical research communications.

[41]  M. Wibo,et al.  PROTEIN DEGRADATION IN CULTURED CELLS , 1974, The Journal of cell biology.

[42]  P. Tulkens,et al.  Commentary. Lysosomotropic agents. , 1974, Biochemical pharmacology.

[43]  Sverre O. Lie,et al.  Inactivation of lysosomal function in normal cultured human fibroblasts by chloroquine. , 1973, Biochemical pharmacology.

[44]  James G. Wilson Environment and birth defects , 1973 .

[45]  N. Lindquist,et al.  Accumulation of Chorio-retinotoxic Drugs in the Foetal Eye , 1970, Nature.

[46]  J. Lloyd,et al.  Lysosomal Enzyme Inhibition by Trypan Blue: A Theory of Teratogenesis , 1967, Science.

[47]  C. W. Hart,et al.  THE OTOTOXICITY OF CHLOROQUINE PHOSPHATE. , 1964, Archives of otolaryngology.

[48]  H. Fritz-Niggli,et al.  Antiteratogenic and anticarcinogenic effects of X-rays in urethane-treated NMRI mice. , 1987, International journal of radiation biology and related studies in physics, chemistry, and medicine.

[49]  I Mellman,et al.  Acidification of the endocytic and exocytic pathways. , 1986, Annual review of biochemistry.

[50]  D. Wall,et al.  Endocytic uptake, transport, and catabolism of proteins by epithelial cells. , 1985, The American journal of physiology.